AIMC Topic: Progression-Free Survival

Clear Filters Showing 21 to 30 of 45 articles

Personalised Medicine for Colorectal Cancer Using Mechanism-Based Machine Learning Models.

International journal of molecular sciences
Gaining insight into the mechanisms of signal transduction networks (STNs) by using critical features from patient-specific mathematical models can improve patient stratification and help to identify potential drug targets. To achieve this, these mod...

Sex Differences in the Association Between Inflammation and Event-Free Survival in Patients With Heart Failure.

The Journal of cardiovascular nursing
BACKGROUND: Heart failure (HF) is associated with chronic inflammation, which is adversely associated with survival. Although sex-related differences in inflammation have been described in patients with HF, whether sex-related differences in inflamma...

Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma.

Clinical cancer research : an official journal of the American Association for Cancer Research
PURPOSE: Several biomarkers of response to immune checkpoint inhibitors (ICI) show potential but are not yet scalable to the clinic. We developed a pipeline that integrates deep learning on histology specimens with clinical data to predict ICI respon...

Non-invasive decision support for NSCLC treatment using PET/CT radiomics.

Nature communications
Two major treatment strategies employed in non-small cell lung cancer, NSCLC, are tyrosine kinase inhibitors, TKIs, and immune checkpoint inhibitors, ICIs. The choice of strategy is based on heterogeneous biomarkers that can dynamically change during...

Intensity harmonization techniques influence radiomics features and radiomics-based predictions in sarcoma patients.

Scientific reports
Intensity harmonization techniques (IHT) are mandatory to homogenize multicentric MRIs before any quantitative analysis because signal intensities (SI) do not have standardized units. Radiomics combine quantification of tumors' radiological phenotype...

Cancer gene expression profiles associated with clinical outcomes to chemotherapy treatments.

BMC medical genomics
BACKGROUND: Machine learning (ML) methods still have limited applicability in personalized oncology due to low numbers of available clinically annotated molecular profiles. This doesn't allow sufficient training of ML classifiers that could be used f...

Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma.

Blood cancer journal
Non-Hodgkin B-cell lymphomas (B-NHLs) are a highly heterogeneous group of mature B-cell malignancies. Their classification thus requires skillful evaluation by expert hematopathologists, but the risk of error remains higher in these tumors than in ma...